A.M. Vitals: FDA Panel Votes to Strip Avastin’s Breast Cancer Indication
Also: Harvard Med School tightens its rules on faculty-industry involvement; WellPoint exec leaves; Chamber of Commerce sets up health-overhaul complaint site.
Read more on Wall Street Journal Blogs

July 24th, 2010
Admin
Posted in
Tags: